The Latest Breaking News from 340B

Drug companies complain that the 340B drug discount program has expanded beyond its original intent of helping safety net providers.

As they lose out on billing for such drugs, hospitals and clinics are trying to convince states to limit this practice, known as "white bagging."

Hospitals and community and rural health clinics that serve low-income patients say drug manufacturers have threatened their financial stability by dramatically cutting back their participation in a federal drug discount program that saves those health providers millions of dollars a year.

American Hospital Association v. Becerra is another indication that lower courts are too quick to give agencies Chevron deference.

The Supreme Court says the federal government improperly lowered drug reimbursement payments to hospitals and clinics that serve low-income communities

Negotiated prices with insurers are often double what the hospital paid to acquire the drug, according to a new study.

Focus on finding ways to substantially reduce the number of pharmacy deserts in Illinois.